FMO5 and hypertensive disorder: Thus, we propose that AMPK decreases blood pressure, abolishes the generation of ROS, and enhances the activity of the ERK1/2-RSK-nNOS pathway by negatively regulating Racl-induced NADPH oxidase levels in the RVLM during oxidative stress–associated hypertension (Fig. 5).